← Back to Search

Monitoring Device for Lung Cancer

N/A

Waitlist Available

Led By Maria Werner-Wasik, MD

Research Sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 4 weeks post-radiation therapy

Awards & highlights

Study Summary

This trial is testing a new device that may help doctors monitor and manage adult patients with lung cancer who are undergoing radiation therapy.

Eligible Conditions

Lung Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 4 weeks post-radiation therapy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 4 weeks post-radiation therapy

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks post-radiation therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of days per study period that patients wear the Automated Device for Asthma Monitoring and Management device

Percentage of hours per day that patients wear the Automated Device for Asthma Monitoring and Management device

Trial Design

1Treatment groups

Experimental Treatment

Group I: Device Feasibility (ADAMM)Experimental Treatment1 Intervention

Patients wear the Automated Device for Asthma Monitoring and Management (ADAMM) from the time of computed tomography (CT) simulation for radiation therapy (RT) planning throughout the entire RT course and for 4 weeks post-RT

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Monitoring Device

2018

Completed Phase 2

~2380

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityLead Sponsor

162 Previous Clinical Trials

10,887 Total Patients Enrolled

Health Care Originals, Inc.UNKNOWN

Maria Werner-Wasik, MDPrincipal InvestigatorSidney Kimmel Cancer Center at Thomas Jefferson University

8 Previous Clinical Trials

203 Total Patients Enrolled

Media Library

Monitoring Device Clinical Trial Eligibility Overview. Trial Name: NCT03340714 — N/A

Lung Cancer Research Study Groups: Device Feasibility (ADAMM)

Monitoring Device 2023 Treatment Timeline for Medical Study. Trial Name: NCT03340714 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for volunteers in this medical experiment?

"The data posted on clinicaltrials.gov indicates that the study in question has ceased enrolling participants since November 29th 2022, when it was last updated. Nonetheless, there are 1510 other trials actively recruiting patients at this moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy

2018. "Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03340714.